Compare ICCC & ACCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICCC | ACCL |
|---|---|---|
| Founded | 1982 | 2009 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.5M | 57.8M |
| IPO Year | 1987 | 2025 |
| Metric | ICCC | ACCL |
|---|---|---|
| Price | $4.90 | $3.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 18.4K | ★ 102.6K |
| Earning Date | 11-13-2025 | 12-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.91 |
| EPS | ★ 0.26 | 0.08 |
| Revenue | ★ $27,769,304.00 | $4,888,824.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $18.59 | $49.06 |
| Revenue Growth | ★ 16.49 | 11.91 |
| 52 Week Low | $3.75 | $2.10 |
| 52 Week High | $7.60 | $5.00 |
| Indicator | ICCC | ACCL |
|---|---|---|
| Relative Strength Index (RSI) | 38.84 | N/A |
| Support Level | $4.52 | N/A |
| Resistance Level | $5.36 | N/A |
| Average True Range (ATR) | 0.29 | 0.00 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 25.33 | 0.00 |
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.